An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome

Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome

(2011) C. N. Andrews et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Combination of Allergic Factors Can Worsen Diarrheic Irritable Bowel Syndrome: Role of Barrier Defects and Mast Cells

(2011) M Vivinus-Nébot et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Intestinal Serotonin Release, Sensory Neuron Activation and Abdominal Pain in Irritable Bowel Syndrome

(2011) Cesare Cremon et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Pharmacology of the New Treatments for Lower Gastrointestinal Motility Disorders and Irritable Bowel Syndrome

(2011) M Camilleri   CLINICAL PHARMACOLOGY & THERAPEUTICS

Brain–Gut Interactions Increase Peripheral Nociceptive Signaling in Mice With Postinfectious Irritable Bowel Syndrome

(2011) Charles Ibeakanma et al.   GASTROENTEROLOGY

The Tryptophan Hydroxylase Inhibitor LX1031 Shows Clinical Benefit in Patients With Nonconstipating Irritable Bowel Syndrome

(2011) Philip M. Brown et al.   GASTROENTEROLOGY

Impaired Uptake of Serotonin by Platelets From Patients With Irritable Bowel Syndrome Correlates With Duodenal Immune Activation

(2011) Stephen Foley et al.   GASTROENTEROLOGY

Origin of increased fecal serine protease in patients with irritable bowel syndrome and diarrhoea (IBS-D)

(2011) K. Garsed et al.   GUT

Identifying and testing candidate genes underlying the inflammatory basis of irritable bowel syndrome

(2011) R. Spiller et al.   GUT

Association of TNFSF15 polymorphism with irritable bowel syndrome

(2011) M. Zucchelli et al.   GUT

Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice

(2011) Clarence C Tam et al.   GUT

Genetic Risk Factors for Post-Infectious Irritable Bowel Syndrome Following a Waterborne Outbreak of Gastroenteritis

(2010) Alexandra–Chloé Villani et al.   GASTROENTEROLOGY

The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome

(2010) T. K. Klooker et al.   GUT

Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery

(2010) J. K. Marshall et al.   GUT

Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study

(2009) R. CORINALDESI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mucosal Immune Activation in Irritable Bowel Syndrome: Gender-Dependence and Association With Digestive Symptoms

(2009) Cesare Cremon et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

T-Cell Activation in Patients With Irritable Bowel Syndrome

(2009) Lena Öhman et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Development of functional gastrointestinal disorders after Giardia lambliainfection

(2009) Kurt Hanevik et al.   BMC GASTROENTEROLOGY

Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers

(2009) Lotta Krogius-Kurikka et al.   BMC GASTROENTEROLOGY

Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: Role of corticotropin-releasing factor receptors

(2009) Cornelia Kiank et al.   BRAIN BEHAVIOR AND IMMUNITY

Activation of Human Enteric Neurons by Supernatants of Colonic Biopsy Specimens From Patients With Irritable Bowel Syndrome

(2009) Sabine Buhner et al.   GASTROENTEROLOGY

Postinfectious Irritable Bowel Syndrome

(2009) Robin Spiller et al.   GASTROENTEROLOGY

Post inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms

(2009) j. simpson et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: Results 3 years after gastroenteritis

(2009) Fermín Mearin et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Bacterial succession in the colon during childhood and adolescence: molecular studies in a southern Indian village

(2008) Ramadass Balamurugan et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Enhanced Cholinergic-Mediated Increase in the Pro-Inflammatory Cytokine IL-6 in Irritable Bowel Syndrome: Role of Muscarinic Receptors

(2008) Timothy G. Dinan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Effects of 5-Hydroxytryptamine (Serotonin) Type 3 Antagonists on Symptom Relief and Constipation in Nonconstipated Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

(2008) Viola Andresen et al.   Clinical Gastroenterology and Hepatology

Structural and functional changes of the duodenum in human norovirus infection

(2008) H. Troeger et al.   GUT

Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain

(2008) A Akbar et al.   GUT

The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors

(2008) Kwang Jae Lee et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Afferent hypersensitivity in a mouse model of post-inflammatory gut dysfunction: role of altered serotonin metabolism

(2008) Christopher Keating et al.   JOURNAL OF PHYSIOLOGY-LONDON

Prolonged elevation of galanin and tachykinin expression in mucosal and myenteric enteric nerves in trinitrobenzene sulphonic acid colitis

(2008) j. simpson et al.   NEUROGASTROENTEROLOGY AND MOTILITY

A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome

(2008) Kei Matsueda et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY